Skip to content
Review

[Early diagnosis in interstitial lung diseases and its impact].

2026 · Medicina · Vol 86 4, pp. 994-1003 · 0 citations
Medicine

TL;DR

Overall, early diagnosis in fibrosing ILD should be regarded as a therapeutic intervention in itself, capable of modifying the natural history of the disease, improving quality of life, and reducing both the economic and emotional burden for patients and healthcare systems.

View source

Similar papers

Open access Sep 2026

Interstitial lung disease misdiagnosis with cardiac pulmonary congestion: a prospective study of misclassification and predictive imaging markers

Interstitial lung disease (ILD) and cardiac pulmonary congestion often present with overlapping clinical and radiological features, leading to frequent diagnostic challenges. Accurate differentiation during the acute worsening of the ILD worsening is essential to guide appropriate management. To determine the frequency...

Hend M. Sayed, S. M. Elkossi, Marwan S. Mahmoud et al. · 0 citations
Review Open access Sep 2026

[Early recognition of fibrosing interstitial lung disease: practical recommendations for initial evaluation and referral].

Fibrosing interstitial lung diseases (ILDs) represent a major diagnostic challenge due to the non-specific nature of their initial symptoms and the frequent delay in diagnosis. Exertional dyspnoea and persistent dry cough are often attributed to more prevalent conditions, which may delay referral. In this context, prim...

F. Camporro, V. Moyano · 0 citations
Open access Sep 2026

Pulmonary hypertension in interstitial lung disease: today's realities, tomorrow's possibilities.

Interstitial lung disease-associated pulmonary hypertension (ILD-PH) is a frequent and life-limiting complication of fibrotic lung disease, associated with substantial morbidity, impaired functional capacity, and significantly reduced survival. Under-recognition remains common due to overlapping symptoms with ILD, evol...

Debabrata Bandyopadhyay, Jorden E. Smith, H. Asif et al. · 0 citations
Review Open access Aug 2026

Korean Clinical Practice Guidelines for Interstitial Lung Disease: Part 2. Idiopathic Pulmonary Fibrosis

This updated guideline draws on evidence published over the past 5 years and covers the epidemiology, pathogenesis, risk factors, clinical manifestations, diagnosis, treatment, comorbidities, prognosis, and acute exacerbations of IPF.

H. Choi, Hee-Young Yoon, So Young Park et al. · 0 citations
Open access Sep 2026

Utility of lung ultrasound in assessing severity of interstitial lung diseases: correlation with high-resolution computed tomography and spirometry findings.

Interstitial lung diseases (ILDs) constitute a diverse category of diffuse parenchymal lung disorders whose diagnosis and monitoring are challenging due to complex clinic-radiological profiles and the risks of serial high-resolution computed tomography (HRCT). Lung ultrasound (LUS) has potential to become an easily ava...

Ramandeep Singh, Naresh Kumar, G. Pradhan et al. · 0 citations
Review Open access Sep 2026

Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review

Abstract Introduction Progressive fibrosing interstitial lung diseases (PF-ILDs), including idiopathic pulmonary fibrosis (IPF), are characterised by irreversible fibrosis and poor prognosis. Despite the importance of timely identification, diagnostic delays remain common. This review aimed to summarise studies reporti...

Zhong-Yi Deng, Stefan Karrasch, P. Alter et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.